These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 24284851)

  • 1. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
    Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
    Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic neuropathy: new strategies for treatment.
    Várkonyi T; Kempler P
    Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
    Quilici S; Chancellor J; Löthgren M; Simon D; Said G; Le TK; Garcia-Cebrian A; Monz B
    BMC Neurol; 2009 Feb; 9():6. PubMed ID: 19208243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
    van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
    Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
    Bellows BK; Dahal A; Jiao T; Biskupiak J
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):153-64. PubMed ID: 22509775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.
    Lindner MD; Bourin C; Chen P; McElroy JF; Leet JE; Hogan JB; Stock DA; Machet F
    Exp Clin Psychopharmacol; 2006 Feb; 14(1):42-51. PubMed ID: 16503704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
    O'Connor AB; Noyes K; Holloway RG
    Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
    Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA
    Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inquiry: what medications are best for diabetic neuropathic pain?
    Page N; Deluca J; Crowell K
    J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Career lifetime advances and key developments: diabetes.
    Baglioni P; Govindan J; Khan A
    Clin Med (Lond); 2007 Jun; 7(3):303-4. PubMed ID: 17639617
    [No Abstract]   [Full Text] [Related]  

  • 13. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.
    Carlos F; Ramírez-Gámez J; Dueñas H; Galindo-Suárez RM; Ramos E
    J Med Econ; 2012; 15(2):233-44. PubMed ID: 22082033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
    Ziegler D; Schneider E; Boess FG; Berggren L; Birklein F
    J Diabetes Complications; 2014; 28(5):698-704. PubMed ID: 24862108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
    Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
    Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsants for fibromyalgia.
    Üçeyler N; Sommer C; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010782. PubMed ID: 24129853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
    Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
    Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
    Ruessmann HJ;
    J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.